Current thinking on malignant salivary gland neoplasms
Rodrigo Arrangoiz*, Pavlos Papavasiliuo, David Sarcu, Thomas J. Galloway, John A. Ridge, Miriam Lango
Temple University, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia USA 19111
Email address:
rodrigo.arrangoiz@gmail.com(R. Arrangoiz), pavlos.papavasiliuo@fccc.edu(P. Papavasiliuo), david.sarcu@tuhs.temple.edu(D. Sarcu), thomas.galloway@fccc.edu(T. J. Galloway), john.ridge@fccc.edu(J. A. Ridge), miriam.lango@fccc.edu(M. Lango)
To cite this article:
Rodrigo Arrangoiz, Pavlos Papavasiliuo, David Sarcu, Thomas J. Galloway, John A. Ridge, Miriam Lango. Current Thinking on Malignant Salivary Gland Neoplasms. Journal of Cancer Treatment and Research. Vol. 1, No. 1, 2013, pp. 8-24.
doi: 10.11648/j.jctr.20130101.12
Click to access a8c039c6e049d0c696bb936662de04c16bf1.pdf
Abstract:Malignant salivary gland neoplasms are rare, representing approximately 3% to 7% of all head and neck cancers. Contrasting from the more common mucosal head and neck cancers, which, in general, are ascribed to excessive tobacco, alcohol use, and more recently to viral infection, specific carcinogenic factors for malignant salivary gland growths have not been as clearly identified. Histologically, they represent a heterogeneous group of tumors. Forty histologic types of epithelial tumors of the salivary glands have been reported; some are exceedingly rare and may be the topic of only a few case reports. Salivary tumors can arise in the major salivary glands or in one of the minor salivary glands (predominantly mucus secreting glands), which are distributed throughout the upper aerodigestive. Most patients who develop malignant salivary gland tumors are in the sixth or seventh decade of life. FNA should be considered as part of the diagnostic evaluation but due to its varying sensitivities and specificities imaging modalities such as ultrasound, CT scans, and MRI should also be used as diagnostic adjuncts. Surgery is the primary modality for management of these tumors, nontraditional surgical approaches and instrumentation, as well as facial nerve monitoring, can be selectively utilized to try and decrease the morbidity associated with these surgical procedures. Adjuvant treatment is primarily achieved with radiation therapy. Chemotherapy continues to have a palliative role in the management of salivary gland tumors; however, research in this field is trying to identify a therapeutic role for chemotherapy in order to improve overall survival.
Keywords: Salivary Gland Tumors, Epidemiology of Salivary Gland Tumors, Types of Salivary Gland Tumors, Diagnosis and Treatment of Salivary Gland Tumors
Book Chapter
Malignant Salivary Gland Neoplasms Literature Review
Rodrigo Arrangoiz*, Fernando Cordera, David Caba, Luis Fernando Negrete, Manuel Muñoz Juarez, Eduardo Moreno Paquentin and Enrique Luque de León
Sociedad Quirúrgica S.C. at the American British Cowdray Medical Center, Mexico
*Corresponding Author: Rodrigo Arrangoiz, Av. Carlos Graef Fernandez # 154 – 515, Colonia Tlaxala, Delegación Cuajimalpa, Mexico City 05300, Mexico, Tel: (5255) 16647200; Email: rodrigo.arrangoiz@gmail.com
First Published February 28, 2018
Abstract
Malignant salivary gland neoplasms represent approximately 3% to 7% of all head and neck cancers making them extremely rare tu- mors. Contrasting from the more common mucosal head and neck cancers, which, in general, are attributed to excessive tobacco, alcohol use, and more recently to viral infection, specific carcinogenic factors for malignant salivary gland growths have not been as clearly identi- fied. Histologically, they represent a heterogeneous group of tumors. Salivary tumors can arise in the major salivary glands or in one of the minor salivary glands (predominantly mucus secreting glands), which are distributed throughout the upper aerodigestive. Most pa- tients who develop malignant salivary gland tumors are in the sixth or seventh decade of life. FNA should be considered as part of the di- agnostic evaluation but due to its varying sensitivities and specificities imaging modalities such as ultrasound, CT scans, and MRI should also be used as diagnostic adjuncts. Surgery is the primary modality for management of these tumors, nontraditional surgical approaches and instrumentation, as well as facial nerve monitoring, can be selectively utilized to try and decrease the morbidity associated with these surgical procedures. Adjuvant treatment is primarily achieved with radiation therapy. Chemotherapy continues to have a palliative role in the management of salivary gland tumors; however, research in this field is trying to identify a therapeutic role for chemotherapy in order to improve overall survival.
Click to access malignant-salivary-gland-neoplasms-literature-review.pdf
Cirugía General y Gastrointestinal
Michigan State University
Cirugía Oncológica
Drexel University
Certificado por el Colegio Americano de Cirugía
Sociedad Quirúrgica S.C.
Hospital ABC Santa Fé
Av. Carlos Graef Fernández #154
Col. Tlaxala, Delg. Cuajimalpa
México, D.F. 05300
Tel: 1103 – 1600 Ext 4515 a la 4517
Fax:1664 – 7164
